TY - JOUR
T1 - Concentration- and time-dependent effects of γ-linolenic acid supplementation to tumor cells in culture
AU - Hrelia, S.
AU - Pession, A.
AU - Buda, R.
AU - Lorenzini, A.
AU - Horrobin, D. F.
AU - Biagi, P. L.
AU - Bordoni, A.
PY - 1999/4
Y1 - 1999/4
N2 - Gamma-linolenic acid (GLA) supplemented to neuroblastoma SK-N-BE, tubal carcinoma TG and colon carcinoma SW-620 cells was incorporated into phospholipids in all the cell lines (although to different extents), in a concentration- and time-dependent manner. All the cell lines were able to metabolize GLA to arachidonic acid, SK-N-BE being the most active. Supplementation with low GLA concentrations for short periods was not sufficient to impair cell proliferation; only higher amounts of GLA had an anti-proliferative effect also in short times. In these conditions, the antiproliferative effect of GLA is probably due to cellular dysfunction caused by fatty acid modifications.
AB - Gamma-linolenic acid (GLA) supplemented to neuroblastoma SK-N-BE, tubal carcinoma TG and colon carcinoma SW-620 cells was incorporated into phospholipids in all the cell lines (although to different extents), in a concentration- and time-dependent manner. All the cell lines were able to metabolize GLA to arachidonic acid, SK-N-BE being the most active. Supplementation with low GLA concentrations for short periods was not sufficient to impair cell proliferation; only higher amounts of GLA had an anti-proliferative effect also in short times. In these conditions, the antiproliferative effect of GLA is probably due to cellular dysfunction caused by fatty acid modifications.
UR - http://www.scopus.com/inward/record.url?scp=0033057389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033057389&partnerID=8YFLogxK
U2 - 10.1054/plef.1999.0030
DO - 10.1054/plef.1999.0030
M3 - Article
C2 - 10397404
AN - SCOPUS:0033057389
SN - 0952-3278
VL - 60
SP - 235
EP - 241
JO - Prostaglandins Leukotrienes and Essential Fatty Acids
JF - Prostaglandins Leukotrienes and Essential Fatty Acids
IS - 4
ER -